Igiciro gito Hubei Vanz API Trilostane Powder CAS 13647-35-3 kuri Kanseri y'ibere hamwe n'ingwate yo kohereza ku isi yose
Ibisobanuro bigufi:
Kanseri y'inkondo y'umura, ni ikibyimba kibi gikunze kugaragara mu nzira y'igifu, iyi kanseri ikurikira kanseri yo mu gifu n'umuhogo, ni yo kanseri ikunze kugaragara cyane ya kanseri y'inkondo y'umura (hafi 60%). Umubare munini w'abarwayi bafite imyaka irenga 40, naho 15% bari munsi y'imyaka 30. Abagabo ni bo bakunze kugaragara cyane, igipimo cy'abagabo ku bagore ni 2-3:1 nk'uko byagaragajwe n'abaganga, byagaragaye ko igice cya kanseri y'inkondo y'umura giterwa na polyps cyangwa schistosomiasis; kubyimba amara igihe kirekire, bimwe bishobora gutera kanseri; indyo irimo ibinure byinshi na poroteyine nyinshi bitera kwiyongera kwa aside ya cholic, iyi ya nyuma ihinduka unsaturated polycyclic hydrocarbons na anaerobics yo mu mara, ishobora no gutera kanseri.
Iyi sosiyete ikomeje kugendera ku gitekerezo cy’imikorere "ubuyobozi bwa siyansi, ireme ry’ikirenga n’imikorere myiza, umukiriya w’ikirenga ku giciro gito Hubei Vanz API Trilostane Powder CAS 13647-35-3 kuri kanseri y’ibere hamwe n’ingwate y’ubwikorezi ku isi yose, Twibanda ku kubaka ikirango cyacu kandi hamwe n’ibikoresho byinshi by’uburambe n’ibigezweho. Ibicuruzwa byacu birakwiye.
Isosiyete ikomeje kugendera ku gitekerezo cy'imikorere "ubuyobozi bwa siyansi, ireme ry'ikirenga n'imikorere y'ibanze, umukiriya w'ikirenga kuriUbushinwa Trilostane na 13647-35-3, Isosiyete yacu ifata "ibiciro biri ku rugero, igihe cyo gukora neza na serivisi nziza nyuma yo kugurisha" nk'amahame yacu. Twifuza gukorana n'abakiriya benshi kugira ngo dutere imbere kandi twungukire hamwe. Twakira abaguzi bashobora kutuvugisha.
Impamvu zitera kanseri y'inkondo y'umura
Kubyimba amara igihe kirekire
Kanseri yo kurwara adenoma y'amara
Indyo n'ibitera kanseri
Uburyo 3 bwo gusuzuma kanseri y'inkondo y'umura
1. Gusuzuma urutoki mu kibuno: uburyo bworoshye ni ugusuzuma urutoki mu kibuno, ubusanzwe bukoreshwa mu gusuzuma kanseri y'inyuma, ni ukuvuga gukoresha uturindantoki tudasesereza kugira ngo hamenyekane niba hari kanseri y'inyuma iturutse mu kibuno.
2. Isuzuma ry'amashusho: isuzuma ririmo CT na MRI, binyuze mu isuzuma rya CT na MRI, kugira ngo harebwe niba hari ukwiyongera kudasanzwe kw'urukuta rw'amara, kugira ngo harebwe niba hari kanseri y'inkondo y'umura.
3. Enteroscopy: enteroscopy ni yo ikoresha uburyo bworoshye bworoshye, hamwe na enteroscopy, binyuze mu gushyiramo aho icyibandwaho hamwe na enteroscopy, hanyuma hagakurikiraho pathology ya biopsy kugira ngo hamenyekane isuzuma. Isosiyete ikomeza kugendera ku gitekerezo cy'imikorere "ubuyobozi bwa siyansi, ireme ryisumbuyeho n'imikorere myiza, umukiriya w'ikirenga ku giciro gito Hubei Vanz API Trilostane Powder CAS 13647-35-3 kuri Kanseri y'ibere hamwe n'ingwate yo kohereza ibicuruzwa ku isi yose, Twibanda ku kubaka ikirango cyacu kandi hamwe n'ibikoresho byinshi by'uburambe n'ibikoresho byo mu rwego rwa mbere. Ibicuruzwa byacu ukwiye kubigura.
Igiciro gitoUbushinwa Trilostane na 13647-35-3, Isosiyete yacu ifata "ibiciro biri ku rugero, igihe cyo gukora neza na serivisi nziza nyuma yo kugurisha" nk'amahame yacu. Twifuza gukorana n'abakiriya benshi kugira ngo dutere imbere kandi twungukire hamwe. Twakira abaguzi bashobora kutuvugisha.
